Kaleido Biosciences
(OTC) KLDO
Kaleido Biosciences Financials at a Glance
Market Cap
$4,300
Revenue (TTM)
$1.10M
Net Income (TTM)
$91.95M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
3414.29 (High)
Dividend
$0.00
Beta (Volatility)
3414.29 (High)
Price
$0.00
Volume
3
Open
$0.00
Price
$0.00
Volume
3
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.35
Dividend
$0.00
Beta (Volatility)
3414.29 (High)
Price
$0.00
Volume
3
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.35
KLDO News
KLDO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kaleido Biosciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
76
CEO
Daniel L. Menichella, MBA
Website
www.kaleido.comHeadquarters
Lexington, MA 02421, US
KLDO Financials
Key Financial Metrics (TTM)
Gross Margin
-1%
Operating Margin
-79%
Net Income Margin
-82%
Return on Equity
0%
Return on Capital
-4%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.30K
Shares Outstanding
42.62M
Volume
3
Short Interest
0.00%
Avg. Volume
25.81K
Financials (TTM)
Gross Profit
$1.25M
Operating Income
$87.67M
EBITDA
$85.09M
Operating Cash Flow
$77.09M
Capital Expenditure
$1.13M
Free Cash Flow
$78.22M
Cash & ST Invst.
$38.47M
Total Debt
$21.69M
Kaleido Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$492.00K
+102.5%
Gross Profit
$492.00K
+102.5%
Gross Margin
100.00%
N/A
Market Cap
$4.30K
N/A
Market Cap/Employee
$56.58
N/A
Employees
76
N/A
Net Income
$21.12M
-8.6%
EBITDA
$18.95M
-1.2%
Quarterly Fundamentals
Net Cash
$16.78M
-33.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$5.55M
-69.8%
Short Term Debt
$16.14M
+512.9%
Return on Assets
-1.80%
N/A
Return on Invested Capital
-4.29%
N/A
Free Cash Flow
$17.60M
-47.1%
Operating Cash Flow
$17.16M
-51.9%